Nathan A Pennell, MD PhD

Taussig Cancer CenterCleveland, Ohio - 44195 |
- CLINICAL TRIALS 1
- CONDITIONS2
- INTERVENTIONS1
- SINCE2007

Erlotinib in Patients With Resected Early Stage NSCLC With Confirmed Mutations in the EGFR
December 2007 - December 2010
Lung Neoplasms
Carcinoma, Non-Small-Cell Lung
Erlotinib



